Literature DB >> 12593889

Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks' gestation.

Paulino Vigil-De Gracia1, Carlos Montufar-Rueda, Juan Ruiz.   

Abstract

BACKGROUND: Timing of delivery is difficult to judge in preeclampsia.
OBJECTIVE: To compare the differences of maternal and perinatal outcome of patients with severe preeclampsia and essential hypertension with superimposed preeclampsia, with expectant management at 24-34 weeks' gestation. STUDY
DESIGN: A retrospective review of a conservative regime using intravenous magnesium sulfate, glucocorticoids and antihypertensive drugs, monitored by serial liver function tests, full blood count, coagulation profile, and renal function tests. Fetal status was assessed by daily non-stress test and ultrasound twice by week.
RESULTS: A total number of 100 women had severe preeclampsia and 29 superimposed preeclampsia. The average pregnancy prolongation was 8.4 and 8.5 days, respectively. Oliguria, abruption placentae and HELLP syndrome were frequent complications similar in each group. There were no cases of eclampsia or disseminated coagulopathy in either group. The total neonatal survival rate was 93% in both groups.
CONCLUSION: Expectant management is equally safe in both superimposed preeclampsia and severe preeclampsia of early onset.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12593889     DOI: 10.1016/s0301-2115(02)00269-5

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  11 in total

1.  An analysis of expectant management in women with early-onset preeclampsia in China.

Authors:  Q Chen; F Shen; Y F Gao; M Zhao
Journal:  J Hum Hypertens       Date:  2014-10-23       Impact factor: 3.012

2.  Severe preterm preeclampsia: an examination of outcomes by race.

Authors:  Jessica A Peterson; Kirsten Sandgren; Lisa D Levine
Journal:  Am J Obstet Gynecol MFM       Date:  2020-07-22

3.  Endothelial nitric oxide synthase gene G894T polymorphism and risk assessment for pregnancy-induced hypertension: evidence from 11 700 subjects.

Authors:  Qiong Ma; Jianmin Lv; Kuikui Huang; Huaqi Guo; Wenliang Yang; Wen Luo; Jie Qiu; Lan Yang
Journal:  Hypertens Res       Date:  2016-07-28       Impact factor: 3.872

4.  Adverse maternal and neonatal outcomes among women with preeclampsia with severe features <34 weeks gestation with versus without comorbidity.

Authors:  Kartik K Venkatesh; Robert A Strauss; Daniel J Westreich; John M Thorp; David M Stamilio; Katherine L Grantz
Journal:  Pregnancy Hypertens       Date:  2020-03-10       Impact factor: 2.899

5.  N-Acetyl-L-cysteine and aminooxyacetic acid differentially modulate trichloroethylene reproductive toxicity via metabolism in Wistar rats.

Authors:  Anthony L Su; Lawrence H Lash; Ingrid L Bergin; Faith Bjork; Rita Loch-Caruso
Journal:  Arch Toxicol       Date:  2021-02-18       Impact factor: 5.153

6.  Study of platelet indices in pregnancy-induced hypertension.

Authors:  Jaya Manchanda; Ajay Malik
Journal:  Med J Armed Forces India       Date:  2019-05-31

7.  Hypertension in Pregnancy: A Community-Based Study.

Authors:  Bharti Mehta; Vijay Kumar; Sumit Chawla; Sandeep Sachdeva; Debjyoti Mahopatra
Journal:  Indian J Community Med       Date:  2015 Oct-Dec

8.  Prevalence of hypertensive disorders of pregnancy and pregnancy outcomes in Sub-Saharan Africa: A systematic review and meta-analysis.

Authors:  Kasiye Shiferaw Gemechu; Nega Assefa; Bizatu Mengistie
Journal:  Womens Health (Lond)       Date:  2020 Jan-Dec

9.  Assessing multidimensional care coverage for pre-eclampsia in the era of universal health coverage: A pre-post evaluation of the Salud Mesoamérica Initiative.

Authors:  Aruna M Kamath; Casey K Johanns; Maximillian G Thom; Rebecca M Cogen; Diego Rios-Zertuche; Ali H Mokdad; Bernardo Hernández
Journal:  Int J Gynaecol Obstet       Date:  2020-03-25       Impact factor: 3.561

10.  Maternal and Fetal Outcomes of Pregnancy-related Hypertensive Disorders in a Tertiary Care Hospital in Sukkur, Pakistan.

Authors:  Shoaib Un Nisa; Altaf A Shaikh; Raj Kumar
Journal:  Cureus       Date:  2019-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.